1 | read read more march | | | | | | | 2 | 0.31% |
2 | monitoring cognitive impairment through | | | | | | | 2 | 0.31% |
3 | sensitivity of speechbased digital | | | | | | | 2 | 0.31% |
4 | the sensitivity of speechbased | | | | | | | 2 | 0.31% |
5 | about careers news contact | | | | | | | 2 | 0.31% |
6 | province of ontario revera | | | | | | | 1 | 0.16% |
7 | ontario centres of excellence | | | | | | | 1 | 0.16% |
8 | centres of excellence province | | | | | | | 1 | 0.16% |
9 | of excellence province of | | | | | | | 1 | 0.16% |
10 | excellence province of ontario | | | | | | | 1 | 0.16% |
11 | winterlight labs menu icon | | | | | | 1 | 0.16% |
12 | whats new january 11 | | | | | | | 1 | 0.16% |
13 | january 11 2023 cambridge | | | | | | | 1 | 0.16% |
14 | 11 2023 cambridge cognition | | | | | | | 1 | 0.16% |
15 | 2023 cambridge cognition and | | | | | | | 1 | 0.16% |
16 | cambridge cognition and winterlight | | | | | | | 1 | 0.16% |
17 | cognition and winterlight labs | | | | | | | 1 | 0.16% |
18 | new january 11 2023 | | | | | | | 1 | 0.16% |
19 | ventures ontario bioscience innovation | | | | | | | 1 | 0.16% |
20 | organization ontario centres of | | | | | | | 1 | 0.16% |
21 | forces to lead in | | | | | | | 1 | 0.16% |
22 | novatio ventures ontario bioscience | | | | | | | 1 | 0.16% |
23 | toronto novatio ventures ontario | | | | | | | 1 | 0.16% |
24 | of toronto novatio ventures | | | | | | | 1 | 0.16% |
25 | university of toronto novatio | | | | | | | 1 | 0.16% |
26 | jlabs mars discovery district | | | | | | | 1 | 0.16% |
27 | johnsonjohnson jlabs mars discovery | | | | | | | 1 | 0.16% |
28 | agewell johnsonjohnson jlabs mars | | | | | | | 1 | 0.16% |
29 | institute agewell johnsonjohnson jlabs | | | | | | | 1 | 0.16% |
30 | partnership with ontario brain | | | | | | | 1 | 0.16% |
31 | in partnership with ontario | | | | | | | 1 | 0.16% |
32 | developed in partnership with | | | | | | | 1 | 0.16% |
33 | team developed in partnership | | | | | | | 1 | 0.16% |
34 | the team developed in | | | | | | | 1 | 0.16% |
35 | join forces to lead | | | | | | | 1 | 0.16% |
36 | voice and digital biomarkers | | | | | | | 1 | 0.16% |
37 | to lead in voice | | | | | | | 1 | 0.16% |
38 | in monitoring cognitive impairment | | | | | | | 1 | 0.16% |
39 | detecting longitudinal change in | | | | | | | 1 | 0.16% |
40 | in detecting longitudinal change | | | | | | | 1 | 0.16% |